Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 169

    1.

    Effects of injectable or implantable progestin-only contraceptives on insulin-glucose metabolism and diabetes risk.

    Kahn HS, Curtis KM, Marchbanks PA.

    Diabetes Care. 2003 Jan;26(1):216-25. Review.PMID: 12502684 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Metabolic parameter, bleeding, and weight changes in U.S. women using progestin only contraceptives.

    Mainwaring R, Hales HA, Stevenson K, Hatasaka HH, Poulson AM, Jones KP, Peterson CM.

    Contraception. 1995 Mar;51(3):149-53.PMID: 7621683 [PubMed - indexed for MEDLINE]Related articles

    3.

    A comparative study of one-year weight gain among users of medroxyprogesterone acetate, levonorgestrel implants, and oral contraceptives.

    Moore LL, Valuck R, McDougall C, Fink W.

    Contraception. 1995 Oct;52(4):215-9.PMID: 8605778 [PubMed - indexed for MEDLINE]Related articles

    4.

    Insulin sensitivity is unaltered by the use of the Norplant subdermal implant contraceptive.

    Koopersmith TB, Lobo RA.

    Contraception. 1995 Mar;51(3):197-200.PMID: 7621688 [PubMed - indexed for MEDLINE]Related articles

    5.

    The effect of Norplant on glucose metabolism under hyperglycemic hyperinsulinemic conditions.

    Shamma FN, Rossi G, HajHassan L, Penzias AS, Connoly-Diamond M, Jones E, Diamond MP.

    Fertil Steril. 1995 Apr;63(4):767-72.PMID: 7890060 [PubMed - indexed for MEDLINE]Related articles

    6.

    Steroidal contraceptives: effect on carbohydrate metabolism in women without diabetes mellitus.

    Lopez LM, Grimes DA, Schulz KF.

    Cochrane Database Syst Rev. 2007 Apr 18;(2):CD006133. Review.PMID: 17443615 [PubMed - indexed for MEDLINE]Related articles

    7.

    Hormonal versus non-hormonal contraceptives in women with diabetes mellitus type 1 and 2.

    Visser J, Snel M, Van Vliet HA.

    Cochrane Database Syst Rev. 2006 Oct 18;(4):CD003990. Review.PMID: 17054193 [PubMed - indexed for MEDLINE]Related articles

    8.

    A comparison of levonorgestrel implants with depo-medroxyprogesterone acetate injections for contraception.

    London RS.

    J SOGC. 1993 Oct;15(8):925-8, 32.PMID: 12318530 [PubMed - indexed for MEDLINE]Related articles

    9.

    Effects of two progestin-only contraceptives, Depo-Provera and Norplant-II, on the vaginal epithelium of rhesus monkeys.

    Hild-Petito S, Veazey RS, Larner JM, Reel JR, Blye RP.

    AIDS Res Hum Retroviruses. 1998 Apr;14 Suppl 1:S125-30.PMID: 9581896 [PubMed - indexed for MEDLINE]Related articles

    10.

    Adolescents' reasons for and experience after discontinuation of the long-acting contraceptives Depo-Provera and Norplant.

    Harel Z, Biro FM, Kollar LM, Rauh JL.

    J Adolesc Health. 1996 Aug;19(2):118-23.PMID: 8863083 [PubMed - indexed for MEDLINE]Related articles

    11.

    Effects of desogestrel on carbohydrate metabolism.

    Shoupe D.

    Am J Obstet Gynecol. 1993 Mar;168(3 Pt 2):1041-7. Review.PMID: 8447358 [PubMed - indexed for MEDLINE]Related articles

    12.

    Contraception in the diabetic woman.

    Kjos SL.

    Clin Perinatol. 1993 Sep;20(3):649-61. Review.PMID: 8222475 [PubMed - indexed for MEDLINE]Related articles

    13.

    Ask the experts: progestin-only contraceptives.

    Hatcher RA, Schnare S.

    Contracept Technol Update. 1993 Jul;14(7):114-5.PMID: 12286999 [PubMed - indexed for MEDLINE]Related articles

    14.

    [Oral contraception, glucid metabolism and monitoring criteria]

    Gaspard U.

    Contracept Fertil Sex (Paris). 1988 Feb;16(2):113-8. French. PMID: 12342000 [PubMed - indexed for MEDLINE]Related articles

    15.

    Comparison of metabolic and inflammatory outcomes in women who used oral contraceptives and the levonorgestrel-releasing intrauterine device in a general population.

    Morin-Papunen L, Martikainen H, McCarthy MI, Franks S, Sovio U, Hartikainen AL, Ruokonen A, Leinonen M, Laitinen J, Järvelin MR, Pouta A.

    Am J Obstet Gynecol. 2008 Nov;199(5):529.e1-529.e10. Epub 2008 Jun 4.PMID: 18533124 [PubMed - indexed for MEDLINE]Related articles

    16.

    Use of Norplant in women with or at-risk for noninsulin-dependent diabetes.

    Womack J, Beal MW.

    J Nurse Midwifery. 1996 Jul-Aug;41(4):285-96. Review.PMID: 8828314 [PubMed - indexed for MEDLINE]Related articles

    17.

    Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women.

    Buchanan TA, Xiang AH, Peters RK, Kjos SL, Marroquin A, Goico J, Ochoa C, Tan S, Berkowitz K, Hodis HN, Azen SP.

    Diabetes. 2002 Sep;51(9):2796-803.PMID: 12196473 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Coordinate changes in plasma glucose and pancreatic beta-cell function in Latino women at high risk for type 2 diabetes.

    Xiang AH, Wang C, Peters RK, Trigo E, Kjos SL, Buchanan TA.

    Diabetes. 2006 Apr;55(4):1074-9.PMID: 16567531 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Long-acting injectable progestin contraception and risk of type 2 diabetes in Latino women with prior gestational diabetes mellitus.

    Xiang AH, Kawakubo M, Kjos SL, Buchanan TA.

    Diabetes Care. 2006 Mar;29(3):613-7.PMID: 16505515 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Effects of race and family history of type 2 diabetes on metabolic status of women with polycystic ovary syndrome.

    Ehrmann DA, Kasza K, Azziz R, Legro RS, Ghazzi MN; PCOS/Troglitazone Study Group.

    J Clin Endocrinol Metab. 2005 Jan;90(1):66-71. Epub 2004 Oct 26.PMID: 15507516 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data